Article info

PDF
Original article
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

Authors

  1. Correspondence to Dr Matti A Rookus, Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands; m.rookus{at}nki.nl
View Full Text

Citation

Brohet RM, Velthuizen ME, Hogervorst FBL, et al
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

Publication history

  • Received August 4, 2013
  • Revised October 15, 2013
  • Accepted October 22, 2013
  • First published November 27, 2013.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.